{"id":1068368,"date":"2023-01-18T00:35:46","date_gmt":"2023-01-18T05:35:46","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/theriva-biologics-to-participate-in-the-b-riley-securities-3rd-annual-oncology-conference\/"},"modified":"2024-08-18T11:46:25","modified_gmt":"2024-08-18T15:46:25","slug":"theriva-biologics-to-participate-in-the-b-riley-securities-3rd-annual-oncology-conference","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/theriva-biologics-to-participate-in-the-b-riley-securities-3rd-annual-oncology-conference.php","title":{"rendered":"Theriva Biologics to Participate in the B. Riley Securities 3rd Annual Oncology Conference"},"content":{"rendered":"<p><![CDATA[ROCKVILLE, Md., Jan.  17, 2023  (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (\u201cTheriva\u201d or the \u201cCompany\u201d), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that Company\u2019s Management will provide a corporate update and participate in one-on-one investor meetings at the the B. Riley Securities 3rd Annual Oncology Conference, to be held virtually from January 18-19, 2023.]]><\/p>\n<p>The rest is here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2023\/01\/17\/2590499\/0\/en\/Theriva-Biologics-to-Participate-in-the-B-Riley-Securities-3rd-Annual-Oncology-Conference.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Theriva Biologics to Participate in the B. Riley Securities 3rd Annual Oncology Conference\">Theriva Biologics to Participate in the B. Riley Securities 3rd Annual Oncology Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The rest is here: Theriva Biologics to Participate in the B. Riley Securities 3rd Annual Oncology Conference <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/theriva-biologics-to-participate-in-the-b-riley-securities-3rd-annual-oncology-conference.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068368","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068368"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068368"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068368\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068368"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068368"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068368"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}